Screened human serum - a+
Ended Purchase Order Awarded Last action
- Contract number
- W81XWH20P0119
- Awardee
-
Zen-Bio, Inc. UEI LQS2WJFBBUQ3
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $178,836
Award facts
- Opportunity
-
- Human Blood and Serum Pre-Solicitation · W81XWH20Q0102 · Posted May 26, 2020
- Contract value 90% obligated
-
- $178,836.00 Current, with exercised options
- $198,336.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20910, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$7,827 | |
| Exercise an Option | $35,056 | |
| Exercise an Option | $32,370 | |
| Exercise an Option | $32,370 | |
| Change Order | $3,555 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $32,370 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $0 | |
| Original award | $50,942 |
Show all 11
About this award
The Defense Health Agency awarded a $198,336 firm fixed-price purchase order to Zen-Bio, Inc. (doing business as Zenbio) on August 15, 2020, for the provision of screened human serum type A+. The contract, which is not set aside for any specific business category, will be performed at Zenbio's location in Silver Spring, Maryland, with an ultimate completion date of August 14, 2025. Zenbio, a Durham, North Carolina-based manufacturer of human blood products and biological materials, was selected through a pre-solicitation opportunity posted on May 26, 2020.
Zenbio has established itself as a specialized supplier of blood products to federal agencies, including the Centers for Disease Control and Prevention, National Heart, Lung, and Blood Institute, and the Defense Health Agency. The company's contract portfolio demonstrates its capacity to support critical medical research and public health initiatives across multiple federal departments. This particular award for screened A+ human serum aligns with the Defense Health Agency's mission to support medical readiness and research through the procurement of specialized biological materials for military health system requirements and research endeavors.
Quick answers
Who was awarded contract W81XWH20P0119?
W81XWH20P0119 was awarded to Zen-Bio, Inc. by Defense Health Agency (Department of Defense) on August 15, 2020.
How much is contract W81XWH20P0119 worth?
The government has obligated $178,836 on W81XWH20P0119. Its potential value, with all options, is $198,336.
Was contract W81XWH20P0119 competed?
The extent of competition for W81XWH20P0119 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award